Literature DB >> 4690061

Histopathological and neuropharmacological aspects of malignant hyperpyrexia.

F R Ellis, N P Keaney, D G Harriman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4690061      PMCID： PMC1644370     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  2 in total

1.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

2.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321
  2 in total
  8 in total

1.  Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.

Authors:  Cecilia Giulivi; Catherine Ross-Inta; Alicja Omanska-Klusek; Eleonora Napoli; Danielle Sakaguchi; Genaro Barrientos; Paul D Allen; Isaac N Pessah
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

Authors:  B A Britt; L Endrenyi; P L Peters; F H Kwong; L Kadijevic
Journal:  Can Anaesth Soc J       Date:  1976-05

Review 3.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

4.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

5.  Central-core disease and malignant hyperpyrexia.

Authors:  D G Harriman; F R Ellis
Journal:  Br Med J       Date:  1973-03-03

6.  A rat model of spontaneous myopathy and malignant hyperthermia.

Authors:  L E Gonzalez; C V Meléndez-Vásquez; N A Gregson; S E File
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11

8.  Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

Authors:  B A Britt; W Frodis; E Scott; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1982-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.